Genetic polymorphisms in CYP1B1, GSTA1, NQO1 and NAT2 and the risk of lung cancer

This publication has 17 references indexed in Scilit:

• Cytochrome P450 Gene Polymorphism and Cancer
  Current Drug Metabolism, 2004
• Glutathione S-transferase T1 null-genotype is associated with an increased risk of lung cancer
  International Journal of Cancer, 2004
• Association of CYP17, CYP19, CYP1B1 , and COMT Polymorphisms with Serum and Urinary Sex Hormone Concentrations in Postmenopausal Women
  Cancer Epidemiology, Biomarkers & Prevention, 2004
• Polymorphisms in the NAD(P)H: quinone oxidoreductase gene and small cell lung cancer risk in a UK population
  Lung Cancer, 2001
• Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression
  Pharmacogenetics, 2001
• The role of human glutathione S-transferases (hGSTs) in the detoxification of the food-derived carcinogen metabolite N-acetoxy-PhIP, and the effect of a polymorphism in hGSTA1 on colorectal cancer risk
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2001
• Localization of N-Acetyltransferases NAT1 and NAT2 in Human Tissues
  Toxicological Sciences, 2000
• Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer
  Pharmacogenetics, 2000
• Catalytic properties of polymorphic human cytochrome P450 1B1 variants
  Carcinogenesis: Integrative Cancer Research, 1999
• Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase)
  British Journal of Cancer, 1997